Neurol. praxi. 2022;23(5):418-420 | DOI: 10.36290/neu.2021.078

Cerebral venous thrombosis and the importance of farmacological history

MUDr. Zuzana Hanzelková1, doc. MUDr. Ondřej Volný, Ph.D.1, 2, MUDr. Jana Slonková, Ph.D.1, 2, MUDr. Pavla Hanzlíková, Ph.D.3, 4, prof. MUDr. Michal Bar, Ph.D.1, 2
1 Neurologická klinika, Fakultní nemocnice Ostrava
2 Katedra a centrum klinických neurověd, Lékařská fakulta, Ostravská univerzita
3 Radiodiagnostický ústav Fakultní nemocnice Ostrava
4 Ústav zobrazovacích metod, Lékařská fakulta, Ostravská univerzita

Cerebral venous thrombosis is a rare form of stroke that most commonly affects women of childbearing potential. The presentation of the case report points to the possible non-specificity of clinical symptoms and the importance of obtaining propper pharmacological history. The patient was examined for non-specific neck pain and headache. Native CT scan of the brain showed no structural pathology, no severe elevation of inflammatory parameters was found and a lumbar puncture ruled out neuroinfection. The diagnosis of cerebral vein thrombosis was only revealed by MRI angiography. Originally the patient did not mention taking of any medication, however after MR examination in a targeted inquiry she supplemented her use of hormonal contraceptives.

Keywords: cerebral venous thrombosis, oral contraceptives, headache.

Received: September 24, 2021; Revised: September 29, 2021; Accepted: October 13, 2021; Prepublished online: October 13, 2021; Published: October 6, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hanzelková Z, Volný O, Slonková J, Hanzlíková P, Bar M. Cerebral venous thrombosis and the importance of farmacological history. Neurol. praxi. 2022;23(5):418-420. doi: 10.36290/neu.2021.078.
Download citation

References

  1. Amoozegar F, Ronksley PE, Sauve R, Menon BK. Hormonal contraceptives and cerebral venous thrombosis risk: a systematic review and meta­‑analysis. Front Neurol. 2015;6:7. Go to original source... Go to PubMed...
  2. Bousser MG. Cerebral Venous Thrombosis: diagnosis and management. J Neurol. 2000; 247:252-258. Go to original source... Go to PubMed...
  3. Bousser MG, Russell RR. Cerebral Venous Thrombosis. Vol. 1. London, UK: WB Saunders Co., 1997; 9780702019371. Go to original source...
  4. Canhao P, Barinagarrementeria F, Bousser MG, et al. International study on cerebral vein trombosis. Cerebrovasc Dis 2001;11(suppl 4):31. Go to PubMed...
  5. Coutinho JM, Zuurbier SM, Bousser MG, et al. Effect of Endovascular Treatment With Medical Management vs Standard Care on Severe Cerebral Venous Thrombosis: The TO­‑ACT Randomized Clinical Trial. JAMA Neurol. 2020;77(8):966-973. Go to original source... Go to PubMed...
  6. Coutinho JM, Zuurbier SM, Aramideh M, Stam J. The incidence of cerebral venous thrombosis. A cross­‑sectional study. Stroke. 2012; 43(12): 3375-3377. Go to original source... Go to PubMed...
  7. Fayyaz M, Abbas F, Kashif T. The Role of Warfarin and Rivaroxaban in the Treatment of Cerebral Venous Thrombosis. Cureus. 2019;11(5):e4589. Go to original source... Go to PubMed...
  8. Ferro JM, Bousser MG, Canhão P, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology. Eur J Neurol. 2017;24(10):1203-1213. Go to original source... Go to PubMed...
  9. Ferro JM, Coutinho JM, Dentali F, et al. Safety and Efficacy of Dabigatran Etexilate vs Dose­‑Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial. JAMA Neurol. 2019;76(12):1457-65. Go to original source... Go to PubMed...
  10. Krajíčková D, Král J, Herzig R, et al. Factors influencing therapy choice and clinical outcome in cerebral venous sinus thrombosis. Sci Rep. 2020;10(1):21633. Go to original source... Go to PubMed...
  11. Lalive PH, de Moerloose P, Lovblad K, et al. Is measurement of D­‑dimer useful in the diagnosis of cerebral venous thrombosis? Neurology. 2003;61(8):1057-60. Go to original source... Go to PubMed...
  12. Liang ZW, Gao WL, Feng LM. Clinical characteristics and prognosis of cerebral venous thrombosis in Chinese women during pregnancy and puerperium. Sci Rep. 2017;7:43866. Go to original source... Go to PubMed...
  13. Meckel S, Reisinger C, Bremerich J, et al. Cerebral venous thrombosis: diagnostic accuracy of combined, dynamic and static, contrast­‑enhanced 4D MR venography. AJNR Am J Neuroradiol. 2010;31(3):527-35. Go to original source... Go to PubMed...
  14. Peisker T, Bartoš A. Mozková žilní trombóza - stále opomíjené onemocnění. Neurol. praxi. 2006;3:160-163.
  15. Sorg A­‑L, Von Kries R, Klemme M, et al. Incidence and risk factors of cerebral sinovenous thrombosis in infants. Dev Med Child Neurol. 2021;63:697-704. Go to original source... Go to PubMed...
  16. Walecki J, Mruk B, Nawrocka­‑Laskus E, et al. Neuroimaging of Cerebral Venous Thrombosis (CVT) - Old Dilemma and the New Diagnostic Methods. Pol J Radiol. 2015;80: 368-373. Go to original source... Go to PubMed...
  17. Zuurbier SM, Arnold M, Middeldorp S, et al. Risk of Cerebral Venous Thrombosis in Obese Women. JAMA Neurol. 2016;73(5): 579-84. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.